Framingham drug developer Sanofi’s new facility has received ... The news comes as the company builds a 900,000-square-foot complex in Cambridge to consolidate much of its Massachusetts ...

Drugmaker Sanofi will keep its presence in Framingham while it consolidates its Massachusetts operations at a new 900,000 square-foot lease in Cambridge.

FRAMINGHAM — Sanofi Genzyme is doubling down on its investment in the Framingham ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in ...

FRAMINGHAM — Sanofi Genzyme is doubling down on its investment in the Framingham ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in ...

PARIS – October 15, 2019 – Sanofi today celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital ...

Sanofi acquired Genzyme for a little over $20 billion back in 2011. Genzyme has historically focused its efforts on rare inherited disorders, kidney diseases, cancer, transplant and immune disease ...

Sanofi’s innovation hub, which employs 2,500 people, is based in Cambridge, Massachusetts. Swiftwater, Pennsylvania contains the company’s vaccine production sites, whilst Framingham ...

French drug maker Sanofi SA, pressing forward with a global realignment, Monday notified about three dozen research and development employees in Massachusetts that their jobs will be eliminated ...

Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing One of the first digital manufacturing facilities in the world to ...